Amplitude-based optimal respiratory gating in positron emission tomography in patients with primary lung cancer

European Radiology

Volumn 24, Issue 12, 2014, Pages 3242-3250

  Grootjans, Willem ^a   de Geus Oei, Lioe Fee ^a,b   Meeuwis, Antoi P W ^a   van der Vos, Charlotte S ^a   Gotthardt, Martin ^a   Oyen, Wim J G ^a   Visser, Eric P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

18 F FDG; Lung cancer; PET CT; Respiratory gating; Standardized uptake value

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; HUMAN; LUNG CANCER; LUNG LOBE; MAJOR CLINICAL STUDY; MALE; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; RESPIRATORY GATED IMAGING; TUMOR VOLUME; ALGORITHM; ARTIFACT; BREATHING; IMAGE PROCESSING; LUNG TUMOR; MIDDLE AGED; PROCEDURES; REPRODUCIBILITY; SCINTISCANNING; VERY ELDERLY; WHOLE BODY IMAGING;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ARTIFACTS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; RESPIRATION; WHOLE BODY IMAGING;

EID: 84911807392     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-014-3362-z     Document Type: Article

References (28)

1. Bentzen SM, Gregoire V (2011) Molecular Imaging–Based Dose Painting: A Novel Paradigm for Radiation Therapy Prescription. Semin Radiat Oncol 2:101–110
2. Berghmans T, Dusart M, Paesmans M et al (2008) Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol 1:6–12
3. Bettinardi V, Picchio M, Di Muzio N, Gilardi MC (2012) Motion Management in Positron Emission Tomography/Computed Tomography for Radiation Treatment Planning. Semin Nucl Med 5:289–307
4. Bomanji JB, Costa DC, Ell PJ (2001) Clinical role of positron emission tomography in oncology. Lancet Oncol 3:157–164
5. Callahan J, Binns D, Dunn L, Kron T (2011) Motion effects on SUV and lesion volume in 3D and 4D PET scanning. Australas Phys Eng Sci Med 4:489–495
6. Carney JPJ, Townsend DW, Rappoport V, Bendriem B (2006) Method for transforming CT images for attenuation correction in PET/CT imaging. Med Phys 4:976–983
7. Chang G, Chang T, Pan T, Clark JW, Mawlawi OR (2010) Implementation of an Automated Respiratory Amplitude Gating Technique for PET/CT: Clinical Evaluation. J Nucl Med 1:16–24
8. Chen HHW, Chiu N-T, Su W-C, Guo H-R, Lee B-F (2012) Prognostic Value of Whole-Body Total Lesion Glycolysis at Pretreatment FDG PET/CT in Non–Small Cell Lung Cancer. Radiology 2:559–566
9. Dawood M, Buther F, Lang N, Schober O, Schafers KP (2007) Respiratory gating in positron emission tomography: A quantitative comparison of different gating schemes. Med Phys 7:3067–3076
10. de Geus-Oei L-F, van der Heijden HFM, Visser EP et al (2007) Chemotherapy Response Evaluation with 18 F-FDG PET in Patients with Non-Small Cell Lung Cancer. J Nucl Med 10:1592–1598
11. de Geus-Oei LF, van Laarhoven HWM, Visser EP et al (2008) Chemotherapy response evaluation with FDG–PET in patients with colorectal cancer. Ann Oncol 2:348–352
12. Dose Schwarz J, Bader M, Jenicke L, Hemminger G, Jänicke F, Avril N (2005) Early Prediction of Response to Chemotherapy in Metastatic Breast Cancer Using Sequential 18 F-FDG PET. J Nucl Med 7:1144–1150
13. Elmpt W, Hamill J, Jones J, Ruysscher D, Lambin P, Öllers M (2011) Optimal gating compared to 3D and 4D PET reconstruction for characterization of lung tumours. Eur J Nucl Med Mol Imaging 5:843–855
14. Erdi YE, Malawi O, Larson SM et al (1997) Segmentation of Lung Lesion Volume by Adaptive Positron Emission Tomography Image Thresholding. Cancer 12:2505–2509
15. Fletcher JW, Djulbegovic B, Soares HP et al (2008) Recommendations on the Use of 18 F-FDG PET in Oncology. J Nucl Med 3:480–508
16. Goerres G, Kamel E, Heidelberg T-N, Schwitter M, Burger C, von Schulthess G (2002) PET-CT image co-registration in the thorax: influence of respiration. Eur J Nucl Med Mol Imaging 3:351–360
17. Hoekstra CJ, Stroobants SG, Smit EF et al (2005) Prognostic Relevance of Response Evaluation Using [18 F]-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Patients With Locally Advanced Non–Small-Cell Lung Cancer. J Clin Oncol 33:8362–8370
18. Jani SS, Robinson CG, Dahlbom M et al (2013) A Comparison of Amplitude-Based and Phase-Based Positron Emission Tomography Gating Algorithms for Segmentation of Internal Target Volumes of Tumors Subject to Respiratory Motion. Int J Radiat Oncol Biol Phys 3:562–569
19. Korreman SS (2012) Motion in radiotherapy: photon therapy. Phys Med Biol 23:R161–R191
20. Mac Manus MP, Hicks RJ, Matthews JP et al (2003) Positron Emission Tomography Is Superior to Computed Tomography Scanning for Response-Assessment After Radical Radiotherapy or Chemoradiotherapy in Patients With Non–Small-Cell Lung Cancer. J Clin Oncol 7:1285–1292
21. Mikhaeel NG, Hutchings M, Fields PA, O'Doherty MJ, Timothy AR (2005) FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma. Ann Oncol 9:1514–1523
22. Nehmeh SA, Erdi YE (2008) Respiratory Motion in Positron Emission Tomography/Computed Tomography: A Review. Semin Nucl Med 3:167–176
23. Nehmeh SA, Erdi YE, Pan T et al (2004) Four-dimensional (4D) PET/CT imaging of the thorax. Med Phys 12:3179–3186
24. Nestle U, Kremp S, Grosu A-L (2006) Practical integration of [18 F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): The technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol: J Eur Soc Ther Radiol Oncol 2:209–225
25. Shankar LK, Hoffman JM, Bacharach S et al (2006) Consensus Recommendations for the Use of 18 F-FDG PET as an Indicator of Therapeutic Response in Patients in National Cancer Institute Trials. J Nucl Med 6:1059–1066
26. Weber WA (2005) Use of PET for Monitoring Cancer Therapy and for Predicting Outcome. J Nucl Med 6:983–995
27. Weber WA, Petersen V, Schmidt B et al (2003) Positron Emission Tomography in Non–Small-Cell Lung Cancer: Prediction of Response to Chemotherapy by Quantitative Assessment of Glucose Use. J Clin Oncol 14:2651–2657
28. Zaizen Y, Azuma K, Kurata S et al (2012) Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy. Eur J Radiol 12:4179–4184